Literature DB >> 27272285

Addressing reimbursement disparities for direct-acting antiviral therapies for hepatitis C virus infection is essential to ensure access for all.

J Grebely1, A Litwin2, G J Dore1.   

Abstract

Entities:  

Keywords:  IFN-free; PWID; drug users; hepatitis C virus; injecting; injection

Mesh：

Substances：

Year:  2016        PMID： 27272285      PMCID： PMC6868522          DOI： 10.1111/jvh.12550

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN： 1352-0504            Impact factor:   3.728


× No keyword cloud information.
  13 in total

1.  EASL Clinical Practice Guidelines: management of hepatitis C virus infection.

Authors: 
Journal:  J Hepatol       Date:  2013-12-09       Impact factor: 25.083

Review 2.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

Authors:  Paul K Nelson; Bradley M Mathers; Benjamin Cowie; Holly Hagan; Don Des Jarlais; Danielle Horyniak; Louisa Degenhardt
Journal:  Lancet       Date:  2011-07-27       Impact factor: 79.321

Review 3.  What is killing people with hepatitis C virus infection?

Authors:  Jason Grebely; Gregory J Dore
Journal:  Semin Liver Dis       Date:  2011-12-21       Impact factor: 6.115

Review 4.  Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis.

Authors:  Esther J Aspinall; Stephen Corson; Joseph S Doyle; Jason Grebely; Sharon J Hutchinson; Gregory J Dore; David J Goldberg; Margaret E Hellard
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

5.  Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States.

Authors:  Soumitri Barua; Robert Greenwald; Jason Grebely; Gregory J Dore; Tracy Swan; Lynn E Taylor
Journal:  Ann Intern Med       Date:  2015-08-04       Impact factor: 25.391

Review 6.  Hepatitis C virus therapeutic development: in pursuit of "perfectovir".

Authors:  Gregory J Dore; Jordan J Feld
Journal:  Clin Infect Dis       Date:  2015-03-11       Impact factor: 9.079

Review 7.  Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis.

Authors:  Rositsa B Dimova; Marija Zeremski; Ira M Jacobson; Holly Hagan; Don C Des Jarlais; Andrew H Talal
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

8.  Recommendations for the management of hepatitis C virus infection among people who inject drugs.

Authors:  Jason Grebely; Geert Robaeys; Philip Bruggmann; Alessio Aghemo; Markus Backmund; Julie Bruneau; Jude Byrne; Olav Dalgard; Jordan J Feld; Margaret Hellard; Matthew Hickman; Achim Kautz; Alain Litwin; Andrew R Lloyd; Stefan Mauss; Maria Prins; Tracy Swan; Martin Schaefer; Lynn E Taylor; Gregory J Dore
Journal:  Int J Drug Policy       Date:  2015-07-17

Review 9.  Epidemiology and natural history of HCV infection.

Authors:  Behzad Hajarizadeh; Jason Grebely; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-02       Impact factor: 46.802

10.  Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network.

Authors:  Z M Younossi; B R Bacon; D T Dieterich; S L Flamm; K Kowdley; S Milligan; N Tsai; A Nezam
Journal:  J Viral Hepat       Date:  2016-02-03       Impact factor: 3.728
View more
  4 in total

1.  Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study.

Authors:  Alison D Marshall; Sahar Saeed; Lisa Barrett; Curtis L Cooper; Carla Treloar; Julie Bruneau; Jordan J Feld; Lesley Gallagher; Marina B Klein; Mel Krajden; Naglaa H Shoukry; Lynn E Taylor; Jason Grebely
Journal:  CMAJ Open       Date:  2016-10-14

2.  Diagnosis and treatment of hepatitis C virus infection: a tool for engagement with people who inject drugs in Vancouver's Downtown Eastside.

Authors:  Arshia Alimohammadi; Julie Holeksa; Robyn Parsons; Rossita Yung; Neilofar Amiri; David Truong; Brian Conway
Journal:  Can Liver J       Date:  2018-07-17

3.  Hepatitis C risk perceptions and attitudes towards reinfection among HIV-diagnosed gay and bisexual men in Melbourne, Australia.

Authors:  Sophia E Schroeder; Peter Higgs; Rebecca Winter; Graham Brown; Alisa Pedrana; Margaret Hellard; Joseph Doyle; Mark Stoové
Journal:  J Int AIDS Soc       Date:  2019-05       Impact factor: 5.396

4.  Real-world Efficacy of Direct-Acting Antiviral Therapy for HCV Infection Affecting People Who Inject Drugs Delivered in a Multidisciplinary Setting.

Authors:  Arshia Alimohammadi; Julie Holeksa; Astou Thiam; David Truong; Brian Conway
Journal:  Open Forum Infect Dis       Date:  2018-05-23       Impact factor: 3.835
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.